# THEOPHYLLINE

NDC: 0121-0820
Generic name: THEOPHYLLINE
Labeler / Manufacturer: PAI Holdings, LLC dba PAI Pharma
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: SOLUTION
Routes: ORAL
Marketing started: 20161216

FDA application: ANDA206344

## Active ingredients

- THEOPHYLLINE: 80 mg/15mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0121-0820"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0121-0820
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=32b9780f-c46f-4e0f-9641-2cab60600e6e